Impedimed Ltd (IPD) - Total Liabilities

Latest as of December 2025: AU$29.34 Million AUD ≈ $20.76 Million USD

Based on the latest financial reports, Impedimed Ltd (IPD) has total liabilities worth AU$29.34 Million AUD (≈ $20.76 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Impedimed Ltd (IPD) cash conversion ratio to assess how effectively this company generates cash.

Impedimed Ltd - Total Liabilities Trend (2006–2025)

This chart illustrates how Impedimed Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Impedimed Ltd (IPD) asset resilience to evaluate the company's liquid asset resilience ratio.

Impedimed Ltd Competitors by Total Liabilities

The table below lists competitors of Impedimed Ltd ranked by their total liabilities.

Company Country Total Liabilities
PT Mitra Pack Tbk
JK:PTMP
Indonesia Rp104.19 Billion
Stockwik Forvaltning AB
ST:STWK
Sweden Skr634.10 Million
Greencore Group
LSE:GNC
UK GBX780.70 Million
Pivotal Metals Ltd
AU:PVT
Australia AU$220.76K
Bd Multimedia
PA:ALBDM
France €2.94 Million
Vesuvius PLC
LSE:VSVS
UK GBX1.16 Billion
BioLineRx Ltd
NASDAQ:BLRX
USA $20.27 Million

Liability Composition Analysis (2006–2025)

This chart breaks down Impedimed Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IPD market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.74 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.25 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.76 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Impedimed Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Impedimed Ltd (2006–2025)

The table below shows the annual total liabilities of Impedimed Ltd from 2006 to 2025.

Year Total Liabilities Change
2025-06-30 AU$21.16 Million
≈ $14.97 Million
+239.00%
2024-06-30 AU$6.24 Million
≈ $4.42 Million
-20.54%
2023-06-30 AU$7.86 Million
≈ $5.56 Million
+2.64%
2022-06-30 AU$7.66 Million
≈ $5.42 Million
-11.92%
2021-06-30 AU$8.69 Million
≈ $6.15 Million
+52.39%
2020-06-30 AU$5.70 Million
≈ $4.04 Million
-16.08%
2019-06-30 AU$6.80 Million
≈ $4.81 Million
+17.88%
2018-06-30 AU$5.76 Million
≈ $4.08 Million
+3.95%
2017-06-30 AU$5.55 Million
≈ $3.92 Million
+4.33%
2016-06-30 AU$5.32 Million
≈ $3.76 Million
+72.60%
2015-06-30 AU$3.08 Million
≈ $2.18 Million
+115.99%
2014-06-30 AU$1.43 Million
≈ $1.01 Million
+12.28%
2013-06-30 AU$1.27 Million
≈ $898.61K
-44.88%
2012-06-30 AU$2.30 Million
≈ $1.63 Million
+8.58%
2011-06-30 AU$2.12 Million
≈ $1.50 Million
-20.82%
2010-06-30 AU$2.68 Million
≈ $1.90 Million
-11.58%
2009-06-30 AU$3.03 Million
≈ $2.14 Million
+36.85%
2008-06-30 AU$2.21 Million
≈ $1.57 Million
-7.16%
2007-06-30 AU$2.39 Million
≈ $1.69 Million
-74.38%
2006-06-30 AU$9.31 Million
≈ $6.59 Million
--

About Impedimed Ltd

AU:IPD Australia Medical Devices
Market Cap
$12.98 Million
AU$18.35 Million AUD
Market Cap Rank
#26215 Global
#1249 in Australia
Share Price
AU$0.01
Change (1 day)
-35.71%
52-Week Range
AU$0.01 - AU$0.06
All Time High
AU$1.68
About

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue compositi… Read more